Reports Outline Psoriasis Findings from Institute of Biomedical Research (The Importance of the Formulation In the Treatment of Psoriasis: the Case of Calcipotriol/betamethasone).

A recent report from the Institute of Biomedical Research in Barcelona, Spain, highlights the importance of formulation in treating psoriasis, specifically focusing on the combination of calcipotriol and betamethasone. The study emphasizes the efficacy and safety of the fixed-dose combination, particularly in the form of foam, compared to other formulations. While more real-world clinical experience is needed to validate the data, the research suggests that calcipotriol/betamethasone foam may be a preferred treatment for managing psoriasis flares and maintenance. The study was supported by LEO Pharma and has been peer-reviewed. [Extracted from the article]